ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1208

Indicators for Active Musculoskeletal Ultrasound Findings of Psoriatic Arthritis Vary on Each Body Part

Shuji Sumitomo1, Shoko Tateishi2, Yoko Soroida3, Harumi Shirai4, Tomomi Iwai5, Kuimiko Ono6, Jun Hirose6, Ayumi Yoshizaki7, Yoshihide Asano8, Shinichi Sato9, Sakae Tanaka6, Hitoshi Ikeda5, Keishi Fujio1, Kazuhiko Yamamoto10 and Hiroko Kanda11, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Department of Immunotherapy Management, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan, 3Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 4Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 5Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 6Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 7Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 8Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan, 9The University of Tokyo, Department of Dermatology, Tokyo, Japan, 10Laboratory for Autoimmune Diseases, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 11Department of Immunotherapy Management, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: psoriatic arthritis and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Imaging of Rheumatic Diseases Poster II: Ultrasound

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Although some global composite measures (DAPSA, DAS28) reflect musculoskeletal ultrasound (MSUS) findings of psoriatic arthritis (PsA), there is little knowledge on how to predict whether certain joints have US active findings. We examined the relationship between composite measure score of PsA and MSUS findings for each body part, and searched for useful indicators for active MSUS findings.

Methods:

Total 98 PsA consecutive cases who fulfilled CASPAR criteria were evaluated. PASDAS, DAPSA, PASI, DAS28-CRP, DAS28-ESR, BASDAI, SDAI, CDAI, CPDAI were calculated using clinical examinations of 68 tender joints, 66 swelling joints, 6 enthesitis and 20 dactylitis. 5 body parts (hand, elbow, shoulder, knee, foot) specific PASDAS, DAPSA were also calculated. MSUS evaluated 60 joints, 16 entheses and 24 tendons. Enthesitis was assessed according to the MASEI investigating the inflammatory scores (entheseal thickening, structural changes, bursitis and vascularization) and chronic damage scores (calcifications, enthesophytes, and erosions). US findings were grouped into 7 body parts (finger, wrist, elbow, shoulder, knee, ankle, toe), and the relationship between composite measure score of PsA and MSUS findings were analyzed using Receiver Operating Characteristic (ROC) curve analysis.

Results:

MSUS PD>=1 in joints were frequent in wrist (13.9 } 3.4%), knee (7.65 } 6.5%) and elbow (13.9 } 3.4%). MSUS enthesitis were frequent in Achilles tendon (inflammatory 18.9%, chronic 29.5%) and knee quadriceps (inflammatory 11.5%, chronic 32.8%). Composite measures predicting active MSUS findings (PD>=1 in joint or tendon, or positive for inflammatory scores of enthestis) were different among body parts (Table 1). In fingers, DAS28-CRP, SDAI, CDAI predict active MSUS findings with moderate accuracy. In wrist, ankle and toe, hand-specific PASDAS, foot-specific PASDAS or foot-specific DAPSA predict active MSUS findings than global PASDAS and DAPSA. On the other hand, in elbow, shoulder and knee, BASDAI predict active MSUS findings with the highest accuracy.

Conclusion:

Composite measures predicting active MSUS findings were different according to body parts. Parts-specific composite measure improved predicting wrist or ankle MSUS findings. Since there is laterality of arthritis or enthesitis of PsA, location specificity is considered to be important than global composite measures. BASDAI is important when considering elbow, shoulder and knee, which is presumably related to the importance of the element of enthesitis in these parts. Careful evaluation according to each part is considered important for prediction of MSUS.

Table 1: Relationship between active MSUS findings in body parts and composite measures (value = AUC).


Disclosure: S. Sumitomo, None; S. Tateishi, None; Y. Soroida, None; H. Shirai, None; T. Iwai, None; K. Ono, None; J. Hirose, None; A. Yoshizaki, None; Y. Asano, None; S. Sato, None; S. Tanaka, None; H. Ikeda, None; K. Fujio, Astellas, BMS, MitsubishiTanabe, Pfizer, Ayumi, Takeda, Chugai, Eisai, Taisho Toyama, Eli Lilly, Sanofi, and UCB, 2; K. Yamamoto, Astellas, BMS, MitsubishiTanabe, Pfizer, Ayumi, Takeda, Chugai, Eisai, Taisho Toyama, UCB, and ImmunoFuture, 2; H. Kanda, Astellas, Eisai, Bristol-Myers, Pfizer Japan, Daiichi-Sankyo, Janssen, Novartis., 5, 8,Tanabe Mitsubishi Pharma, Chugai Pharmaceutical, Ayumi Pharmaceutical, Taisho Toyama Pharmaceutical, Nippon Kayaku, UCB Japan, AbbVie., 9.

To cite this abstract in AMA style:

Sumitomo S, Tateishi S, Soroida Y, Shirai H, Iwai T, Ono K, Hirose J, Yoshizaki A, Asano Y, Sato S, Tanaka S, Ikeda H, Fujio K, Yamamoto K, Kanda H. Indicators for Active Musculoskeletal Ultrasound Findings of Psoriatic Arthritis Vary on Each Body Part [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/indicators-for-active-musculoskeletal-ultrasound-findings-of-psoriatic-arthritis-vary-on-each-body-part/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/indicators-for-active-musculoskeletal-ultrasound-findings-of-psoriatic-arthritis-vary-on-each-body-part/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology